As scrutiny on pharmacy benefit managers mount, a House committee will hold a hearing on the alleged anticompetitive business practices of these middlemen.
As scrutiny on pharmacy benefit managers mount, a House committee will hold a hearing on the alleged anticompetitive business practices of these middlemen.